JPS622947A - 抗微生物表面および該表面による微生物増殖の抑制 - Google Patents
抗微生物表面および該表面による微生物増殖の抑制Info
- Publication number
- JPS622947A JPS622947A JP61132591A JP13259186A JPS622947A JP S622947 A JPS622947 A JP S622947A JP 61132591 A JP61132591 A JP 61132591A JP 13259186 A JP13259186 A JP 13259186A JP S622947 A JPS622947 A JP S622947A
- Authority
- JP
- Japan
- Prior art keywords
- contact
- metal
- silver
- noble metal
- catheter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000001629 suppression Effects 0.000 title description 4
- 241000894006 Bacteria Species 0.000 title description 2
- 230000000844 anti-bacterial effect Effects 0.000 title 1
- 229910052751 metal Inorganic materials 0.000 claims description 97
- 239000002184 metal Substances 0.000 claims description 97
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 53
- 150000002739 metals Chemical class 0.000 claims description 42
- 229910052709 silver Inorganic materials 0.000 claims description 41
- 239000004332 silver Substances 0.000 claims description 41
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 36
- 230000012010 growth Effects 0.000 claims description 29
- 238000000034 method Methods 0.000 claims description 29
- 229910052697 platinum Inorganic materials 0.000 claims description 26
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 23
- 229910052737 gold Inorganic materials 0.000 claims description 22
- 239000010931 gold Substances 0.000 claims description 22
- 230000000845 anti-microbial effect Effects 0.000 claims description 20
- 230000004071 biological effect Effects 0.000 claims description 20
- 239000003792 electrolyte Substances 0.000 claims description 20
- 230000000813 microbial effect Effects 0.000 claims description 17
- 229910052782 aluminium Inorganic materials 0.000 claims description 16
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 16
- 239000004020 conductor Substances 0.000 claims description 13
- 244000005700 microbiome Species 0.000 claims description 13
- 239000000126 substance Substances 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 9
- 239000010970 precious metal Substances 0.000 claims description 6
- 229910000831 Steel Inorganic materials 0.000 claims description 3
- 210000001124 body fluid Anatomy 0.000 claims description 3
- 239000010839 body fluid Substances 0.000 claims description 3
- 239000010959 steel Substances 0.000 claims description 3
- 230000001939 inductive effect Effects 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 229910000510 noble metal Inorganic materials 0.000 claims 17
- 230000002785 anti-thrombosis Effects 0.000 claims 2
- 238000004544 sputter deposition Methods 0.000 claims 2
- 230000017423 tissue regeneration Effects 0.000 claims 2
- 238000012377 drug delivery Methods 0.000 claims 1
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 claims 1
- 238000000576 coating method Methods 0.000 description 16
- 239000011248 coating agent Substances 0.000 description 13
- 230000002485 urinary effect Effects 0.000 description 11
- 230000009036 growth inhibition Effects 0.000 description 10
- 230000009471 action Effects 0.000 description 8
- 230000005764 inhibitory process Effects 0.000 description 8
- 229910021645 metal ion Inorganic materials 0.000 description 8
- 210000001519 tissue Anatomy 0.000 description 8
- 230000001580 bacterial effect Effects 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 239000001963 growth medium Substances 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 150000002500 ions Chemical class 0.000 description 6
- -1 platinum ions Chemical class 0.000 description 6
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 5
- 239000012634 fragment Substances 0.000 description 5
- 208000019206 urinary tract infection Diseases 0.000 description 5
- 201000004538 Bacteriuria Diseases 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000001990 intravenous administration Methods 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 229920001296 polysiloxane Polymers 0.000 description 4
- 210000002700 urine Anatomy 0.000 description 4
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
- 230000003385 bacteriostatic effect Effects 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229910001385 heavy metal Inorganic materials 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 2
- 229910045601 alloy Inorganic materials 0.000 description 2
- 239000000956 alloy Substances 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000004907 flux Effects 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 229940100890 silver compound Drugs 0.000 description 2
- 150000003379 silver compounds Chemical class 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 210000001635 urinary tract Anatomy 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 206010011409 Cross infection Diseases 0.000 description 1
- 208000001860 Eye Infections Diseases 0.000 description 1
- 208000002513 Flank pain Diseases 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 229910021607 Silver chloride Inorganic materials 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- IHWJXGQYRBHUIF-UHFFFAOYSA-N [Ag].[Pt] Chemical compound [Ag].[Pt] IHWJXGQYRBHUIF-UHFFFAOYSA-N 0.000 description 1
- XRZCZVQJHOCRCR-UHFFFAOYSA-N [Si].[Pt] Chemical compound [Si].[Pt] XRZCZVQJHOCRCR-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- XSBJUSIOTXTIPN-UHFFFAOYSA-N aluminum platinum Chemical compound [Al].[Pt] XSBJUSIOTXTIPN-UHFFFAOYSA-N 0.000 description 1
- 230000003872 anastomosis Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 230000003416 augmentation Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 238000001815 biotherapy Methods 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 208000011323 eye infectious disease Diseases 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 208000024386 fungal infectious disease Diseases 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 230000002070 germicidal effect Effects 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- JUWSSMXCCAMYGX-UHFFFAOYSA-N gold platinum Chemical compound [Pt].[Au] JUWSSMXCCAMYGX-UHFFFAOYSA-N 0.000 description 1
- PQTCMBYFWMFIGM-UHFFFAOYSA-N gold silver Chemical compound [Ag].[Au] PQTCMBYFWMFIGM-UHFFFAOYSA-N 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229940127554 medical product Drugs 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000011885 synergistic combination Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0077—Special surfaces of prostheses, e.g. for improving ingrowth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
- A61L29/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Surgery (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Materials For Medical Uses (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/742,662 US4886505A (en) | 1985-06-07 | 1985-06-07 | Antimicrobial surfaces and inhibition of microorganism growth thereby |
| US742662 | 1985-06-07 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS622947A true JPS622947A (ja) | 1987-01-08 |
| JPH025089B2 JPH025089B2 (https=) | 1990-01-31 |
Family
ID=24985734
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP61132591A Granted JPS622947A (ja) | 1985-06-07 | 1986-06-07 | 抗微生物表面および該表面による微生物増殖の抑制 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US4886505A (https=) |
| EP (1) | EP0206024A3 (https=) |
| JP (1) | JPS622947A (https=) |
| AU (2) | AU588598B2 (https=) |
| BR (1) | BR8602637A (https=) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01230368A (ja) * | 1987-08-04 | 1989-09-13 | Carl Freudenberg:Fa | 医療用ツールとその製造方法 |
| JP2009524479A (ja) * | 2006-01-27 | 2009-07-02 | カメレオン サイエンティフィック コーポレイション | 抗菌被覆方法 |
| WO2017150537A1 (ja) * | 2016-02-29 | 2017-09-08 | メドトロニックソファモアダネック株式会社 | 抗菌性生体内埋込用器具 |
| WO2017150534A1 (ja) * | 2016-02-29 | 2017-09-08 | メドトロニックソファモアダネック株式会社 | 抗菌性生体内埋込用器具 |
Families Citing this family (95)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8616294D0 (en) * | 1986-07-03 | 1986-08-13 | Johnson Matthey Plc | Antimicrobial compositions |
| US4728323A (en) * | 1986-07-24 | 1988-03-01 | Minnesota Mining And Manufacturing Company | Antimicrobial wound dressings |
| US5165952A (en) * | 1989-01-18 | 1992-11-24 | Becton, Dickinson And Company | Anti-infective and antithrombogenic medical articles and method for their preparation |
| US6261271B1 (en) | 1989-01-18 | 2001-07-17 | Becton Dickinson And Company | Anti-infective and antithrombogenic medical articles and method for their preparation |
| US5320908A (en) * | 1989-05-04 | 1994-06-14 | Ad Tech Holdings Limited | Deposition of an extremely thin silver layer on a nonconducting substrate |
| FI95816C (fi) * | 1989-05-04 | 1996-03-25 | Ad Tech Holdings Ltd | Antimikrobinen esine ja menetelmä sen valmistamiseksi |
| DE3916648C1 (https=) * | 1989-05-22 | 1990-09-06 | Fa. Carl Freudenberg, 6940 Weinheim, De | |
| CA2033107C (en) * | 1990-12-24 | 2001-06-12 | Robert Edward Burrell | Actively sterile surfaces |
| EP0570452A1 (en) * | 1991-02-06 | 1993-11-24 | Minnesota Mining And Manufacturing Company | Improved surgical hardware with bacteriostatic silver coating, and method of using same |
| US5468562A (en) * | 1991-03-01 | 1995-11-21 | Spire Corporation | Metallized polymeric implant with ion embedded coating |
| US5520664A (en) * | 1991-03-01 | 1996-05-28 | Spire Corporation | Catheter having a long-lasting antimicrobial surface treatment |
| CA2065711A1 (en) * | 1991-04-10 | 1992-10-11 | Walter S. Hennig | Energy dissipation device |
| CA2076574A1 (en) * | 1991-10-01 | 1993-04-02 | John Lenneis Haynes | Extended-life drug filled patch |
| WO1993007924A1 (en) * | 1991-10-18 | 1993-04-29 | Spire Corporation | Bactericidal coatings for implants |
| EP0567627A4 (en) * | 1991-11-14 | 1994-06-22 | Stanley Poler | Secondary eye growth impeding device and method |
| ATE156368T1 (de) * | 1991-12-06 | 1997-08-15 | North Shore Univ Hospital | Verfahren zum vermindern von durch medizinische vorrichtungen bedingten infektionen |
| US5360440A (en) * | 1992-03-09 | 1994-11-01 | Boston Scientific Corporation | In situ apparatus for generating an electrical current in a biological environment |
| US5685961A (en) * | 1992-03-27 | 1997-11-11 | P & D Medical Coatings, Inc. | Method for fabrication of metallized medical devices |
| US5295979A (en) * | 1992-03-27 | 1994-03-22 | P & D Medical Coatings, Inc. | Urinary catheter and system |
| GEP20002074B (en) * | 1992-05-19 | 2000-05-10 | Westaim Tech Inc Ca | Modified Material and Method for its Production |
| US5681575A (en) * | 1992-05-19 | 1997-10-28 | Westaim Technologies Inc. | Anti-microbial coating for medical devices |
| US5492763A (en) * | 1992-06-08 | 1996-02-20 | Spire Corporation | Infection resistant medical devices and process |
| US5260020A (en) * | 1992-09-17 | 1993-11-09 | Wilk Peter J | Method and apparatus for catheter sterilization |
| WO1995013098A1 (en) * | 1992-09-17 | 1995-05-18 | Wilk Peter J | Method and apparatus for catheter sterilization |
| US5409467A (en) * | 1992-10-02 | 1995-04-25 | Board Of Regents, The University Of Texas System | Antimicrobial catheter |
| US5322520A (en) * | 1992-11-12 | 1994-06-21 | Implemed, Inc. | Iontophoretic structure for medical devices |
| US6060000A (en) * | 1992-11-12 | 2000-05-09 | Implemed, Inc. | Iontophoretic material containing carbon and metal granules |
| US6287484B1 (en) | 1992-11-12 | 2001-09-11 | Robert Hausslein | Iontophoretic material |
| DE4316920A1 (de) * | 1993-05-20 | 1994-11-24 | Michael Dr Med Hartmann | Endotrachealer Tubus |
| US5454886A (en) * | 1993-11-18 | 1995-10-03 | Westaim Technologies Inc. | Process of activating anti-microbial materials |
| US6004667A (en) * | 1994-06-30 | 1999-12-21 | Shinshu Ceramics Company, Ltd. | Low temperature melt injected anti-microbial films, articles containing such films and methods of manufacture and use thereof |
| US5593438A (en) * | 1995-01-20 | 1997-01-14 | Akhavi; David S. | Intraocular lens with metallic coatings for preventing secondary cataracts |
| US5629691A (en) * | 1995-05-26 | 1997-05-13 | Hughes Electronics | Airport surface monitoring and runway incursion warning system |
| US5769841A (en) * | 1995-06-13 | 1998-06-23 | Electroscope, Inc. | Electrosurgical apparatus for laparoscopic and like procedures |
| US5814094A (en) | 1996-03-28 | 1998-09-29 | Becker; Robert O. | Iontopheretic system for stimulation of tissue healing and regeneration |
| US7214847B1 (en) | 1997-09-22 | 2007-05-08 | Argentum Medical, L.L.C. | Multilayer conductive appliance having wound healing and analgesic properties |
| US8455710B2 (en) | 1997-09-22 | 2013-06-04 | Argentum Medical, Llc | Conductive wound dressings and methods of use |
| US6861570B1 (en) | 1997-09-22 | 2005-03-01 | A. Bart Flick | Multilayer conductive appliance having wound healing and analgesic properties |
| US6087549A (en) | 1997-09-22 | 2000-07-11 | Argentum International | Multilayer laminate wound dressing |
| US8801681B2 (en) | 1995-09-05 | 2014-08-12 | Argentum Medical, Llc | Medical device |
| US5709672A (en) * | 1995-11-01 | 1998-01-20 | Texas Tech University Health Sciences Center | Silastic and polymer-based catheters with improved antimicrobial/antifungal properties |
| DE19607314A1 (de) * | 1996-02-27 | 1997-08-28 | Orthomed Chirurgische Instr Gm | Antibakterielle Wirkung aufweisender Körper zur Verwendung als medizinisches oder chirurgisches Hilfsmittel |
| US5741224A (en) * | 1996-04-16 | 1998-04-21 | Implemed, Inc. | Iontophoretic material |
| US5759564A (en) * | 1996-04-16 | 1998-06-02 | Implemed, Inc. | Iontophoretic material |
| US6013106A (en) * | 1997-01-22 | 2000-01-11 | St. Jude Medical, Inc. | Medical article with adhered antimicrobial metal ions and related methods |
| US6165484A (en) * | 1997-08-26 | 2000-12-26 | Wake Forest University | EDTA and other chelators with or without antifungal antimicrobial agents for the prevention and treatment of fungal infections |
| MC2461A1 (fr) * | 1997-09-26 | 1998-12-18 | Exsymol Sa | Dispositifs ophtalmiques et implantables recouverts d'un revêtement et procédés pour la production de ces derniers |
| US6365220B1 (en) | 1997-11-03 | 2002-04-02 | Nucryst Pharmaceuticals Corp. | Process for production of actively sterile surfaces |
| US6113636A (en) * | 1997-11-20 | 2000-09-05 | St. Jude Medical, Inc. | Medical article with adhered antimicrobial metal |
| US6267782B1 (en) * | 1997-11-20 | 2001-07-31 | St. Jude Medical, Inc. | Medical article with adhered antimicrobial metal |
| GB2339696A (en) * | 1998-07-21 | 2000-02-09 | Alexander Robert Ead Blacklock | Deposit and encrustation resistant long term urethral catheter |
| US6596401B1 (en) | 1998-11-10 | 2003-07-22 | C. R. Bard Inc. | Silane copolymer compositions containing active agents |
| AU3724900A (en) * | 1999-03-05 | 2000-09-21 | Louis R. Matson | Surface-modified bioactive surgical implants suppressing tissue growth |
| US7344627B2 (en) | 1999-06-08 | 2008-03-18 | Broadley-James Corporation | Reference electrode having a flowing liquid junction and filter members |
| CA2378678C (en) * | 1999-06-08 | 2009-08-04 | Broadley Technologies Corporation | Reference electrode having a microfluidic flowing liquid junction |
| US7943026B2 (en) * | 1999-06-08 | 2011-05-17 | Broadley Technologies Corporation | Reference electrode having a flowing liquid junction and filter members |
| US6282444B1 (en) | 1999-08-31 | 2001-08-28 | Pacesetter, Inc. | Implantable device with electrical infection control |
| US6716895B1 (en) | 1999-12-15 | 2004-04-06 | C.R. Bard, Inc. | Polymer compositions containing colloids of silver salts |
| US7179849B2 (en) | 1999-12-15 | 2007-02-20 | C. R. Bard, Inc. | Antimicrobial compositions containing colloids of oligodynamic metals |
| US6579539B2 (en) | 1999-12-22 | 2003-06-17 | C. R. Bard, Inc. | Dual mode antimicrobial compositions |
| SE0100661D0 (sv) * | 2001-02-27 | 2001-02-27 | St Jude Medical | Implantable heart stimulator |
| SE0100669D0 (sv) * | 2001-02-27 | 2001-02-27 | St Jude Medical | Implantable device |
| SE0100668D0 (sv) * | 2001-02-27 | 2001-02-27 | St Jude Medical | Implantable heart stimulator |
| JP2005511144A (ja) | 2001-12-03 | 2005-04-28 | シー・アール・バード・インク | 微生物耐性医療用具、微生物耐性ポリマーコーティング及びその製造方法 |
| AU2003256448A1 (en) * | 2002-07-03 | 2004-01-23 | Broadley Technologies Corporation | Reference electrode having a microfluidic flowing liquid junction and filter members |
| DK1575550T3 (da) * | 2002-11-19 | 2008-06-16 | Univ Danmarks Tekniske | Anvendelse af biologisk hæmmende materiale til hæmning af levende celler |
| JP2006515387A (ja) * | 2002-12-18 | 2006-05-25 | アイオニック フュージョン コーポレイション | 抗−微生物性表面のイオン性プラズマ堆積、及びそれらから得られる抗−微生物性表面 |
| US8066854B2 (en) * | 2002-12-18 | 2011-11-29 | Metascape Llc | Antimicrobial coating methods |
| US20040191315A1 (en) * | 2003-03-24 | 2004-09-30 | Mike Slattery | Office products containing antimicrobial agent |
| US7465302B2 (en) * | 2004-08-17 | 2008-12-16 | Encision, Inc. | System and method for performing an electrosurgical procedure |
| US7422589B2 (en) * | 2004-08-17 | 2008-09-09 | Encision, Inc. | System and method for performing an electrosurgical procedure |
| US20060041252A1 (en) * | 2004-08-17 | 2006-02-23 | Odell Roger C | System and method for monitoring electrosurgical instruments |
| US7329301B2 (en) * | 2004-09-29 | 2008-02-12 | Eastman Kodak Company | Silver nanoparticles made in solvent |
| US8353881B2 (en) | 2005-12-28 | 2013-01-15 | Abbott Diabetes Care Inc. | Infusion sets for the delivery of a therapeutic substance to a patient |
| DE102006004628A1 (de) * | 2006-01-31 | 2007-08-09 | Landau, Uwe, Prof. Dr. | Oligodynamisch wirksame Vorrichtung und Verfahren zu ihrer Herstellung |
| US7981034B2 (en) | 2006-02-28 | 2011-07-19 | Abbott Diabetes Care Inc. | Smart messages and alerts for an infusion delivery and management system |
| US8007494B1 (en) | 2006-04-27 | 2011-08-30 | Encision, Inc. | Device and method to prevent surgical burns |
| US8251989B1 (en) | 2006-06-13 | 2012-08-28 | Encision, Inc. | Combined bipolar and monopolar electrosurgical instrument and method |
| US9119582B2 (en) | 2006-06-30 | 2015-09-01 | Abbott Diabetes Care, Inc. | Integrated analyte sensor and infusion device and methods therefor |
| US8932216B2 (en) | 2006-08-07 | 2015-01-13 | Abbott Diabetes Care Inc. | Method and system for providing data management in integrated analyte monitoring and infusion system |
| US8206296B2 (en) | 2006-08-07 | 2012-06-26 | Abbott Diabetes Care Inc. | Method and system for providing integrated analyte monitoring and infusion system therapy management |
| US8574610B2 (en) | 2006-09-07 | 2013-11-05 | Biolargo Life Technologies, Inc. | Material having antimicrobial activity when wet |
| EP2084234A2 (en) * | 2006-11-08 | 2009-08-05 | Massachusetts Institute of Technology | Polymeric coatings that inactivate viruses and bacteria |
| TW200901890A (en) * | 2007-04-03 | 2009-01-16 | Sure Internat Ventures B V | New compostions and methods for cell killing |
| US8641618B2 (en) | 2007-06-27 | 2014-02-04 | Abbott Diabetes Care Inc. | Method and structure for securing a monitoring device element |
| US8085151B2 (en) | 2007-06-28 | 2011-12-27 | Abbott Diabetes Care Inc. | Signal converting cradle for medical condition monitoring and management system |
| WO2009032605A2 (en) * | 2007-08-27 | 2009-03-12 | Massachusetts Institute Of Technology | Bi-functional polymer-attached inhibitors of influenza virus |
| US9833281B2 (en) | 2008-08-18 | 2017-12-05 | Encision Inc. | Enhanced control systems including flexible shielding and support systems for electrosurgical applications |
| US8500728B2 (en) | 2008-08-18 | 2013-08-06 | Encision, Inc. | Enhanced control systems including flexible shielding and support systems for electrosurgical applications |
| EP2382960A1 (de) | 2010-04-19 | 2011-11-02 | DERU GmbH Entwicklung von medizinischen Produkten | Implantat mit antimikrobieller Beschichtung |
| GB2493163A (en) * | 2011-07-26 | 2013-01-30 | Ide Technologies Ltd | A method of inhibiting microbially induced corrosion (MIC) |
| US10058455B2 (en) | 2013-06-10 | 2018-08-28 | Ultramend, Inc. | Nano-enhanced wound dressing |
| CN109069188B (zh) * | 2016-02-29 | 2021-08-03 | 美敦力索发摩尔丹耐克有限公司 | 用于抗菌性体内植入装置的固定螺钉 |
| WO2017150542A1 (ja) * | 2016-02-29 | 2017-09-08 | メドトロニックソファモアダネック株式会社 | 抗菌性生体内埋込用器具 |
| DE202019004613U1 (de) * | 2019-11-13 | 2021-02-16 | Stephan Hoffmann | Inhalative Zufuhr (Zufuhr über die Atemluft) von Bakterien, Viren, Bakteriophagen oder Teilen von diesen z.B. durch einen antimikrobiell beschichteten Tubus |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US742802A (en) * | 1903-06-15 | 1903-10-27 | Carlton W Roberts | Galvanic battery. |
| US1042124A (en) * | 1912-04-05 | 1912-10-22 | Gustav Komarek | Car-truck. |
| US4054139A (en) * | 1975-11-20 | 1977-10-18 | Crossley Kent B | Oligodynamic catheter |
| GB1582016A (en) * | 1977-05-16 | 1980-12-31 | Akiyama H | Catheter |
| US4308859A (en) * | 1979-08-01 | 1982-01-05 | Child Laboratories Inc. | Method of inhibiting mastitis in bovine animals |
| US4253463A (en) * | 1979-10-19 | 1981-03-03 | Kim Il B | Method of reducing infection utilizing an intravascular device having antiseptic metal portion |
| US4476590A (en) * | 1980-03-27 | 1984-10-16 | National Research Development Corporation | Antimicrobial surgical implants |
| WO1981002668A1 (en) * | 1980-03-27 | 1981-10-01 | Nat Res Dev | Orthopaedic implants |
| US4483688A (en) * | 1980-09-22 | 1984-11-20 | Hiroshi Akiyama | Catheter |
| US4411648A (en) * | 1981-06-11 | 1983-10-25 | Board Of Regents, The University Of Texas System | Iontophoretic catheter device |
| CH654738A5 (en) * | 1985-02-26 | 1986-03-14 | Ines Blaettler | Surgical implants and repair plates |
-
1985
- 1985-06-07 US US06/742,662 patent/US4886505A/en not_active Expired - Lifetime
-
1986
- 1986-06-03 AU AU58417/86A patent/AU588598B2/en not_active Ceased
- 1986-06-04 EP EP86107598A patent/EP0206024A3/en not_active Withdrawn
- 1986-06-05 BR BR8602637A patent/BR8602637A/pt unknown
- 1986-06-07 JP JP61132591A patent/JPS622947A/ja active Granted
-
1989
- 1989-03-21 AU AU31550/89A patent/AU3155089A/en not_active Abandoned
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01230368A (ja) * | 1987-08-04 | 1989-09-13 | Carl Freudenberg:Fa | 医療用ツールとその製造方法 |
| JP2009524479A (ja) * | 2006-01-27 | 2009-07-02 | カメレオン サイエンティフィック コーポレイション | 抗菌被覆方法 |
| WO2017150537A1 (ja) * | 2016-02-29 | 2017-09-08 | メドトロニックソファモアダネック株式会社 | 抗菌性生体内埋込用器具 |
| WO2017150534A1 (ja) * | 2016-02-29 | 2017-09-08 | メドトロニックソファモアダネック株式会社 | 抗菌性生体内埋込用器具 |
| JPWO2017150537A1 (ja) * | 2016-02-29 | 2019-01-24 | メドトロニックソファモアダネック株式会社 | 抗菌性生体内埋込用器具 |
| JPWO2017150534A1 (ja) * | 2016-02-29 | 2019-01-24 | メドトロニックソファモアダネック株式会社 | 抗菌性生体内埋込用器具 |
Also Published As
| Publication number | Publication date |
|---|---|
| US4886505A (en) | 1989-12-12 |
| EP0206024A3 (en) | 1988-07-20 |
| EP0206024A2 (en) | 1986-12-30 |
| AU3155089A (en) | 1989-06-29 |
| JPH025089B2 (https=) | 1990-01-31 |
| AU5841786A (en) | 1986-12-11 |
| AU588598B2 (en) | 1989-09-21 |
| BR8602637A (pt) | 1987-11-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS622947A (ja) | 抗微生物表面および該表面による微生物増殖の抑制 | |
| ES2405995T3 (es) | Galio que inhibe la formación de biopelículas | |
| US4054139A (en) | Oligodynamic catheter | |
| JP5351174B2 (ja) | 消毒剤組成物、方法およびシステム | |
| EP0580803A1 (en) | Antimicrobial compositions useful for medical applications | |
| US6482309B1 (en) | Electrolytic generation of nascent iodine as a method of treatment and for the prevention of infections associated with medical implant devices | |
| US5409467A (en) | Antimicrobial catheter | |
| Raad et al. | In vitro antimicrobial efficacy of silver iontophoretic catheter | |
| Chakravarti et al. | An electrified catheter to resist encrustation by Proteus mirabilis biofilm | |
| US8128953B2 (en) | Conductive therapeutic coating for medical device | |
| Falcone et al. | Inhibitory effects of electrically activated silver material on cutaneous wound bacteria | |
| Karademir et al. | Antimicrobial surface functionality of PEG coated and AgNPs immobilized extracorporeal biomaterials | |
| JP7138110B2 (ja) | 成熟バイオフィルムに対して有効な、抗菌ヒドロゲルを含む抗菌組成物 | |
| Djokic | Treatment of various surfaces with silver and its compounds for topical wound dressings, catheter and other biomedical applications | |
| CN113069664B (zh) | 一种电活性抗菌促愈导尿管及其制备方法 | |
| US20220233847A1 (en) | Graphene oxide cochlear implant electrode and manufacturing method thereof | |
| US20250185663A1 (en) | Antimicrobial composition and system for delivering an antimicrobial composition | |
| JP2002200172A (ja) | 微生物感染および血栓形成を防止する医療用チューブおよび人工臓器 | |
| Guggenbichler | Prevention of implant associated nosocomial infections | |
| HK1096558B (en) | Gallium inhibits biofilm formation | |
| JPH0713346U (ja) | 細菌感染の予防と治療に役立つ微弱直流通電用電極 | |
| MXPA06006379A (en) | Gallium inhibits biofilm formation |